Synaptic plasticity induction

Synaptic plasticity induction refers to the physiological processes by which synapses—the connections between neurons—are strengthened or weakened in response to patterns of activity. This phenomenon underlies learning, memory formation, and adaptive changes in neural circuits. The most studied forms are long-term potentiation (LTP) and long-term depression (LTD), which depend on activity-dependent changes at excitatory glutamatergic synapses. Induction typically involves activation of postsynaptic NMDA-type glutamate receptors leading to calcium influx, which triggers intracellular signaling cascades involving kinases like CaMKII that modify AMPA receptor function and trafficking. Additional regulatory mechanisms include metaplasticity and homeostatic scaling. While many neurotransmitter systems can modulate synaptic plasticity—including dopamine, acetylcholine, serotonin, GABA—glutamatergic transmission is central. Disruption of these processes is implicated in various neurological diseases. Note: "Synaptic plasticity induction" is *not* a canonical name for any single molecule or therapeutic target but rather describes a complex biological event involving multiple molecular players such as NMDA receptors, AMPA receptors, CaMKII kinase, etc. Therefore: - It should not be classified as an individual druggable target. - For structured data purposes regarding drug targets or biomarkers you should refer instead to specific molecules involved in this process—such as "NMDA receptor," "AMPA receptor," etc.—rather than the general term "synaptic plasticity induction."